Search
-
Evaluating and adapting your soon-to-launch pharma strategy
Covid-19 has greatly disrupted the channels of communication between healthcare professionals and pharma manufacturers, especially those preparing for a product launch.
-
Assessing the risk profile of recently launched drugs
Manufacturers of the 48 launched products since January 2019 are facing a unique challenge in the current Covid-19 market.
-
Level-up Your Segmentation: Connecting with Profitable Targets
View our on demand webinar to learn how we have made segmentation research more engaging.
-
Covid-19 Impact on the Economy & MedTech Industry in China
We shed light on the questions that have arisen regarding the domestic economy, healthcare industry and specifically, the medical devices sector in China.
-
The Power of Payer Insights Tracking
Hear more about the biggest future Payer challenges and how traditional ATUs can be complemented by a more dynamic approach to tracking.
-
Pharma Sales Need to Know About Covid-19 & HCP Practices
Hear results from the first-wave of our new regular Covid-19 HCP Surveillance Research of 300+ HCPs across seven specialties.
-
Medical Devices & Diagnostics Pulse Survey: Diabetes
Check out the latest results from our Medical Devices & Diagnostics Pulse Survey, focusing on Diabetes – with results benchmarked to 2018.
-
Behavioral Science Insights Amidst the Covid-19 Outbreak
Three Behavioral Science Factors you should consider during a pandemic.
-
Future of Fintech: What to Expect in 2020
View our on demand webinar to hear what you can expect in the Fintech space in 2020, post Covid-19.